BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23291634)

  • 1. Ex vivo and in vivo investigations of the effects of extracts of Vernonia amygdalina, Carica papaya and Tapinanthus sessilifolius on digoxin transport and pharmacokinetics: assessing the significance on rat intestinal P-glycoprotein efflux.
    Oga EF; Sekine S; Horie T
    Drug Metab Pharmacokinet; 2013; 28(4):314-20. PubMed ID: 23291634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein mediated efflux in Caco-2 cell monolayers: the influence of herbals on digoxin transport.
    Oga EF; Sekine S; Shitara Y; Horie T
    J Ethnopharmacol; 2012 Dec; 144(3):612-7. PubMed ID: 23064285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
    Zhang H; Yao M; Morrison RA; Chong S
    Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montmorillonite-surfactant hybrid particles for modulating intestinal P-glycoprotein-mediated transport.
    Nielsen RB; Kahnt A; Dillen L; Wuyts K; Snoeys J; Nielsen UG; Holm R; Nielsen CU
    Int J Pharm; 2019 Nov; 571():118696. PubMed ID: 31525443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp.
    Li X; Hu J; Wang B; Sheng L; Liu Z; Yang S; Li Y
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):163-75. PubMed ID: 24380838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
    Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
    Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
    Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.
    Bai J; Zhao S; Fan X; Chen Y; Zou X; Hu M; Wang B; Jin J; Wang X; Hu J; Zhang D; Li Y
    Toxicol Appl Pharmacol; 2019 Apr; 369():49-59. PubMed ID: 30790579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies.
    Martin P; Gillen M; Millson D; Oliver S; Brealey C; Elsby R; Baluom M; Lau D; Mant T
    Clin Ther; 2015 Dec; 37(12):2811-22. PubMed ID: 26514315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
    Zhang Y; Wang C; Liu Z; Meng Q; Huo X; Liu Q; Sun P; Yang X; Sun H; Ma X; Liu K
    Pharmacol Rep; 2018 Apr; 70(2):243-250. PubMed ID: 29475007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species difference in intestinal absorption mechanism of etoposide and digoxin between cynomolgus monkey and rat.
    Nishimura T; Kato Y; Amano N; Ono M; Kubo Y; Kimura Y; Fujita H; Tsuji A
    Pharm Res; 2008 Nov; 25(11):2467-76. PubMed ID: 18626752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.
    Zhang S; Morris ME
    Pharm Res; 2003 Aug; 20(8):1184-91. PubMed ID: 12948016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
    Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
    Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Basal Membrane Permeability of Epithelial Cells in Predicting Intestinal Drug Absorption.
    Yoshitomo A; Asano S; Hozuki S; Tamemoto Y; Shibata Y; Hashimoto N; Takahashi K; Sasaki Y; Ozawa N; Kageyama M; Iijima T; Kazuki Y; Sato H; Hisaka A
    Drug Metab Dispos; 2023 Mar; 51(3):318-328. PubMed ID: 36810197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies.
    Rocha-Pereira C; Ghanem CI; Silva R; Casanova AG; Duarte-Araújo M; Gonçalves-Monteiro S; Sousa E; Bastos ML; Remião F
    Toxicol Appl Pharmacol; 2020 Jan; 386():114832. PubMed ID: 31756430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice.
    Miyake T; Tsutsui H; Haraya K; Tachibana T; Morimoto K; Takehara S; Ayabe M; Kobayashi K; Kazuki Y
    Br J Pharmacol; 2021 Nov; 178(21):4335-4351. PubMed ID: 34232502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of green tea catechins on the pharmacokinetics of digoxin in humans.
    Kim TE; Shin KH; Park JE; Kim MG; Yun YM; Choi DH; Kwon KJ; Lee J
    Drug Des Devel Ther; 2018; 12():2139-2147. PubMed ID: 30022812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran Etexilate and Digoxin: Comparison as Clinical Probe Substrates for Evaluation of P-gp Inhibition.
    Chu X; Galetin A; Zamek-Gliszczynski MJ; Zhang L; Tweedie DJ;
    Clin Pharmacol Ther; 2018 Nov; 104(5):788-792. PubMed ID: 30238965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.